Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

PURPOSE: Hormone receptor-positive (HR+) tumors have heterogeneous biology and present a challenge for determining optimal treatment. In the Neoadjuvant Breast Registry Symphony Trial (NBRST) patients were classified according to MammaPrint/BluePrint subtyping to provide insight into the response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitworth, Pat, Beitsch, Peter, Mislowsky, Angela, Pellicane, James V., Nash, Charles, Murray, Mary, Lee, Laura A., Dul, Carrie L., Rotkis, Michael, Baron, Paul, Stork-Sloots, Lisette, de Snoo, Femke A., Beatty, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306085/
https://www.ncbi.nlm.nih.gov/pubmed/27770345
http://dx.doi.org/10.1245/s10434-016-5600-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306085/
https://www.ncbi.nlm.nih.gov/pubmed/27770345
http://dx.doi.org/10.1245/s10434-016-5600-x

Ejemplares similares